Literature DB >> 10888734

Appropriateness of liver biopsy.

T Poynard1, V Ratziu, P Bedossa.   

Abstract

This review aims to discuss the appropriateness of liver biopsy in two frequent liver diseases, hepatitis C and alcoholic liver disease. The medical literature, published between 1965 and 1999, was reviewed by using MEDLINE. Only 0.1% of the publications were devoted specifically to the appropriateness of liver biopsy. Not all studies observed a significant agreement among doctors on the decision to use liver biopsy. Therefore, there is a possibility that hepatologists have significant, heterogeneous opinions concerning the appropriateness of liver biopsy. Appropriateness should be evaluated for different techniques such as percutaneous liver biopsy, guided or not by ultrasonography, and the types of needles, automatic or not. The present paper reviews the evaluation of liver biopsy appropriateness in the real world, the adverse events and mortality of liver biopsy, and the appropriateness of liver biopsy in alcoholic liver disease and chronic hepatitis C. The authors conclude that liver biopsy is used extensively, but its appropriateness has not been evaluated perfectly. Therefore, further evaluation of the appropriateness of liver biopsy in the practical algorithm of such diseases is needed.

Entities:  

Mesh:

Year:  2000        PMID: 10888734     DOI: 10.1155/2000/107982

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  40 in total

1.  "Liverscore" is predictive of both liver fibrosis and activity in chronic hepatitis C.

Authors:  Shoukat Ali Arain; Qamar Jamal; Amir Omair
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

2.  Platelet count for predicting fibrosis in nonalcoholic fatty liver disease.

Authors:  Masato Yoneda; Hideki Fujii; Yoshio Sumida; Hideyuki Hyogo; Yoshito Itoh; Masafumi Ono; Yuichiro Eguchi; Yasuaki Suzuki; Noriaki Aoki; Kazuyuki Kanemasa; Kento Imajo; Kazuaki Chayama; Toshiji Saibara; Norifumi Kawada; Kazuma Fujimoto; Yutaka Kohgo; Toshikazu Yoshikawa; Takeshi Okanoue
Journal:  J Gastroenterol       Date:  2011-07-13       Impact factor: 7.527

3.  Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C.

Authors:  Tadashi Takeda; Takahiro Yasuda; Yuji Nakayama; Mika Nakaya; Megumi Kimura; Mariko Yamashita; Ayumi Sawada; Koji Abo; Setsuko Takeda; Hiroki Sakaguchi; Susumu Shiomi; Hitoshi Asai; Shuichi Seki
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

4.  The relationship between pediatric nonalcoholic fatty liver disease and cardiovascular risk factors and increased risk of atherosclerosis in obese children.

Authors:  Selim Gökçe; Zehra Atbinici; Zehra Aycan; Hasibe Gökçe Cınar; Pelin Zorlu
Journal:  Pediatr Cardiol       Date:  2012-08-09       Impact factor: 1.655

5.  Support vector machine-based feature selection for classification of liver fibrosis grade in chronic hepatitis C.

Authors:  Zheng Jiang; Kazunobu Yamauchi; Kentaro Yoshioka; Kazuma Aoki; Susumu Kuroyanagi; Akira Iwata; Jun Yang; Kai Wang
Journal:  J Med Syst       Date:  2006-10       Impact factor: 4.460

Review 6.  Magnetic Resonance Elastography of Liver: Current Update.

Authors:  Safa Hoodeshenas; Meng Yin; Sudhakar Kundapur Venkatesh
Journal:  Top Magn Reson Imaging       Date:  2018-10

7.  Assessment of liver fibrosis: noninvasive means.

Authors:  Thierry Poynard; Rachel Morra; Patrick Ingiliz; Françoise Imbert-Bismut; Dominique Thabut; Djamila Messous; Mona Munteanu; Julien Massard; Yves Benhamou; Vlad Ratziu
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

8.  Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI.

Authors:  Ai-Sheng Ho; Chun-Chia Cheng; Shui-Cheng Lee; Meng-Lun Liu; Jing-Ying Lee; Wen-Ming Wang; Chia-Chi Wang
Journal:  J Biomed Sci       Date:  2010-07-15       Impact factor: 8.410

Review 9.  [Liver biopsy at the intersection of clinical and pathological diagnosis].

Authors:  U Spengler; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

Review 10.  Why, who and how should perform liver biopsy in chronic liver diseases.

Authors:  Ioan Sporea; Alina Popescu; Roxana Sirli
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.